CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,392 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 6,373 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel and Secretary gave up 1,950 shares (to pay taxes)
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Chief Executive Officer sold 25,000 shares at an average $51.47 ($1,286,798)
- 4 Open-market sale Chief Executive Officer sold 25,000 shares at an average $40.93 ($1,023,290)
- 4 Option exercise Chief Executive Officer acquired 58,233 shares (option exercise)
- 4 Shares withheld for taxes Chief Executive Officer gave up 19,401 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel and Secretary gave up 3,234 shares (to pay taxes)
- 4 Open-market sale Chief Executive Officer sold 25,000 shares at an average $54.03 ($1,350,827)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Chief Executive Officer sold 25,000 shares at an average $54.81 ($1,370,191)
- 8-K Event Executive or director change
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,111 shares (to pay taxes)
Page 15 of 45 · 883 filings